摘要
近年来 ,许多研究表明 ,各种不同的病因基本是通过足细胞的损伤而启动FSGS的进程。尤其对足细胞多种蛋白分子成分的研究 。
出处
《国外医学(泌尿系统分册)》
2004年第4期556-560,共5页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献17
-
1Endlich N,Kress KR,Reiser J,et al.Podocytes responded to mechanical stress in vitro.J Am Soc Nephrol,2001 12,413~422
-
2Petermann AT,Hiromura K,Blonski M,et al.Mechanical stress reduces podocyte proliferation in vitro.Kidney Int,2002,61(1),40~50
-
3Moudgi A,Nast CC,Bagga A,et al.Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy.Kidney Int,2001,59(16),2126~2133
-
4Kapasi AA,Franki N,Ding G,Singhal PC,Human glomerular epithelial cell express CD4 and interaction with gp120 protein promotes PYK2 tyrosine phosphorylation.Mol Cell Biol Res Commun,1999,1(2),140~143
-
5Pollak MR.The genetic basis of FSGS and steroid-resistant nephrosis.Semin Nephrol,2003,23(2),141~146
-
6Markowitz GS,Appel GB,Fine PL,et al.Collapsing focal segememtal glomerulosclerosis following treatment with high-dose pamidronate.J Am Soc Nephrol,2001,12(6),1164~1172
-
7Schiffer M,Bitzer M,Roberts IS,et al.Apoptosis in podocytes induced by TGF-beta and smad7.J Clin Invest,2001,108(6),807~816
-
8Schiffer M,Schiffer LE,Gupta A,et al.Inhibitory smads and tgf-Bata signaling in glomerular cell.J Am Soc Nephrol,2002,13(11),2657~2666
-
9Kim JH,Kim BK,Moon KC,et al.Activation of the TGF-beta/smad signaling pathwayin Focal segment glomerulosclerosis.Kidney Int,2003,64(5),1715~1721
-
10Prasad Devarajan MD,Adrian Spitzer MD.Towards a biological characterization of Focal segemental glomerulosclerosis.Am J Kidney Dis,2002,39(3),625~635
同被引文献46
-
1李月红,黄海长,章友康,王素霞,邹万忠.局灶节段性肾小球硬化症大鼠尿足细胞动态检测及其意义[J].中华肾脏病杂志,2005,21(2):98-102. 被引量:20
-
2刘东,马俊杰,桂泽红,陈忠华,郑克立.血浆置换治疗移植肾复发性FSGS合并大量蛋白尿的远期观察[J].中华器官移植杂志,2006,27(3):170-172. 被引量:3
-
3曾彩虹,刘志红,苏健,黎磊石.局灶节段性肾小球硬化肾组织形态学特点与临床表现的联系[J].肾脏病与透析肾移植杂志,2006,15(1):18-24. 被引量:12
-
4张亮,马英,华平,刘牧,郎学聪,赵平,聂晓冬,何光莲,林会英.肾病综合征患者血清、尿液转化生长因子β1水平变化相关性研究[J].中国医药,2007,2(4):201-202. 被引量:2
-
5Mark Ham, Meehan SM, Karrison TG, et al. Spargo: Changing etiology of unexplained adult nephrotic syndrome: A comparison of Renal Biopsy Findings from 1976- 1979 and 1995- 1997. Am J Kidney Dis, 1997,30(5) :621 - 631.
-
6Andrei SP. Radcial and ethnic differences in the incidence and progression of focal ,segmental glomerulosclerosis in children. Adv Ren Replace Ther,2004,11 ( 1 ) : 105 - 109.
-
7D' Agati VD, Fogo AB, Bruijn JA, et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis, 2004,43(2) :368 - 382.
-
8Meyrier A. An update on the treatment options for focal segmental glomerulosclerosis. Expert Opin Pharmacother, 2009, 10 (4) :615 - 628.
-
9Mantan M, Sriram CS, Hari P, et al. Efficacy of intravenous pulse eyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyelophosphamide treatment in steroid - resistant nephrotic syndrome. Pediatr Nephrol, 2008,23 (9) : 1495 - 1502.
-
10Plank C, Kalb V, Hinkes B, et al. Cyclosporin a is superior to cyclophosphamide in children with steroid - resistant nephrotic syndrome - a randomized controlled multicentre trial by the Arbeitsgemeinschaft furs Pediatrische Nephrologie. Pediatr Nephrol,2008,23(9) : 1483 - 1493.
引证文献3
-
1刘睿,邓跃毅.原发性局灶节段性肾小球硬化症治疗概况[J].中国中西医结合肾病杂志,2009,10(11):1019-1021. 被引量:2
-
2蒋莹辉,尚文英,曹西田,王欣,赵晓,镡红印,支忠继.双重血浆置换治疗激素抵抗性FSGS疗效观察[J].山东医药,2014,54(46):70-71. 被引量:5
-
3刘国勇,贺理宇,佘健,杨青,徐佳思,崔玲,粟立文.足细胞在泼尼松干预局灶节段硬化性肾小球硬化的机制探讨[J].医学检验与临床,2018,29(2):1-4.
二级引证文献7
-
1杨昕彤,汪裕伟.成人肾病综合征最新治疗进展[J].世界最新医学信息文摘,2021(8):81-83. 被引量:1
-
2姚天文,韩世盛,王怡.局灶节段性肾小球硬化的中西医治疗进展[J].国际泌尿系统杂志,2016,0(2):310-314. 被引量:1
-
3冯双燕,李统宇,黄国东.原发性局灶节段性肾小球硬化治疗研究进展[J].实用中医药杂志,2017,33(2):220-222. 被引量:2
-
4姚转娥,白海霞,爨婷,符涛,刘晨阳,傅薇,王乾.局灶节段性肾小球硬化的治疗进展[J].徐州医科大学学报,2019,39(3):227-231. 被引量:7
-
5匡仟卉柠,高春林,姚俊,夏正坤.局灶节段性肾小球硬化诊治现状[J].临床儿科杂志,2019,37(6):470-474. 被引量:9
-
6彭映潮(综述),高春林,夏正坤(审校).儿童原发性局灶节段性肾小球硬化症治疗进展[J].临床儿科杂志,2021,39(8):631-635. 被引量:1
-
7双重滤过血浆置换在肾脏疾病中临床应用专家组,赵景宏,李冰,左力,熊加川,王沂芹.双重滤过血浆置换在肾脏疾病中临床应用专家共识(2025版)[J].中华肾脏病杂志,2025,41(11):908-918.
-
1聂秀,吴人亮.转化生长因子β在肾间质纤维化中的作用[J].国外医学(泌尿系统分册),2005,25(3):409-412. 被引量:25
-
2刘娜(综述),严海东(审校).肾间质纤维化的发生机制及防治新进展[J].国际泌尿系统杂志,2009,29(1):137-140. 被引量:3
-
3张晓光(综述),傅淑霞(审校).血管内皮生长因子与肾间质纤维化[J].国际泌尿系统杂志,2007,27(6):860-863. 被引量:2
-
4郑东辉,邢昌赢.霉酚酸酯治疗CKD2、3期局灶节段性肾小球硬化疗效观察[J].临床肾脏病杂志,2007,7(6):254-255. 被引量:1
-
5李慧,张玲.脂质、炎症与肾小球硬化[J].国际泌尿系统杂志,2006,26(6):827-831.
-
6魏立新,邹和群.局灶节段性肾小球硬化的临床和研究现状[J].国际泌尿系统杂志,2006,26(1):92-97. 被引量:1
-
7牟利军,贾金康.肾间质纤维化的防治进展[J].国外医学(泌尿系统分册),2005,25(3):405-408. 被引量:2
-
8叶琨,刘伏友,刘映红.肾间质纤维化的防治进展[J].国外医学(泌尿系统分册),2005,25(6):831-837. 被引量:5
-
9张义雄,俞雷.血小板源性生长因子与肾间质纤维化[J].国际泌尿系统杂志,2005,25(S1):67-69. 被引量:1
-
10吴星(综述),朱晓玲(审校),王永钧(审校).CD2AP在局灶节段肾小球硬化症中的研究进展[J].国际泌尿系统杂志,2010,30(2):282-285.